李声义，被责令辞职！

Core Viewpoint - Tong Ren Tang has initiated a series of special actions to address issues related to product quality and management accountability following a recent incident involving its Sichuan Health subsidiary [1][6]. Group 1: Accountability and Responsibility - The company is conducting a comprehensive investigation into the responsibilities of involved units and personnel, leading to the resignation of Li Shengyi as the general manager of Sichuan Health and the suspension of other related management personnel [2][6]. - A working group led by senior executives has been established to take over the management of Sichuan Health, with plans for serious consequences for those found responsible after internal and governmental investigations [2][6]. Group 2: Regulatory Cooperation and Investigation - Tong Ren Tang's team in Sichuan is actively cooperating with a joint investigation by local regulatory authorities, having submitted evidence related to the infringement by Sichuan Health [3][6]. - The company is working to remove and recall affected products while monitoring and blocking the circulation of these products through major e-commerce platforms [3][6]. Group 3: Consumer Guidance and Product Verification - A product information query system was launched on December 23, providing over 1,000 entries for traditional Chinese medicine and health food products, helping consumers identify authentic "Tong Ren Tang" products marked with the "Double Dragon" logo [4][6]. Group 4: Brand Management and Compliance - A brand management initiative has been launched to conduct thorough checks on brand usage across various enterprises, with over 520 inspections completed by December 24 [5][7]. - The initiative has resulted in nearly 600 complaints against infringing products on major e-commerce platforms and actions against over 120 unauthorized stores misusing the Tong Ren Tang name [5][7].